The global laboratory proficiency testing market size was US$ 1.2 billion in 2022. The market is estimated to reach over US$ 2.2 billion in 2032, growing at a CAGR of 6.1% during the forecast period from 2023 to 2032.
Laboratory proficiency testing, which is used to monitor labs' long-term performance, evaluates how well other labs conduct specific tests or metrics. A laboratory proficiency test involves the exchange of artifacts between participating labs. Each laboratory performs the measurements on the items (such as a ring gauge or a set of gauge blocks) in accordance with a predetermined set of criteria and communicates the results to the administrator. The reference value for that purpose is compared to the data reported by each laboratory for a specific purpose.
Market Driving Factors
Regional Analysis
North America dominated the market share in the global laboratory proficiency testing market and is estimated to witness the highest CAGR from 2023 to 2032. Numerous variables, including rising regulatory compliance, technical development, industry cooperation, etc., are responsible for this rapid market growth. Additionally, the presence of significant market participants, an increase in the prevalence of chronic diseases, and growing public awareness of the numerous clinical advantages provided by laboratory proficiency testing are likely to fuel market expansion.
The FDA and Health Canada have imposed strict quality requirements and rules for laboratories. Additionally, laboratories in North America are implementing proficiency testing to guarantee adherence to these rules and exhibit their dedication to quality. Therefore, government-backing initiatives and technological breakthroughs will accelerate regional growth.
Segmentation Analysis
Based on industry, in 2022, the clinical diagnostics segment held the largest revenue share. The large revenue share is due to a rising tendency toward early disease diagnosis and a rising need for the creation of complicated diagnostic tests, among other factors.
Based on technology, in 2022, the cell culture segment dominated the global market. The pharmaceutical sector will expand its use of cell culture due to its many advantages, including the production of vaccines and other goods based on cell culture.
Prominent Companies
Segmentation Outline
The global laboratory proficiency testing market segmentation focuses on Industry, Technology, End-Use, and Region.
By Industry
By Technology
By End-Use
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL LABORATORY PROFICIENCY TESTING MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: LABORATORY PROFICIENCY TESTING MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL LABORATORY PROFICIENCY TESTING MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL LABORATORY PROFICIENCY TESTING MARKET, BY INDUSTRY
5.1 OVERVIEW
5.2 CLINICAL DIAGNOSTICS
5.2.1 CLINICAL CHEMISTRY
5.2.2 IMMUNOCHEMISTRY
5.2.3 HEMATOLOGY
5.2.4 MOLECULAR DIAGNOSTICS
5.2.5 OTHERS
5.3 MICROBIOLOGY
5.3.1 PATHOGEN TESTING
5.3.2 STERILITY TESTING
5.3.3 ENDOTOXIN & PYROGEN TESTING
5.3.4 OTHERS
5.4 PHARMACEUTICALS
5.5 BIOLOGICS
5.6 OTHERS
6 GLOBAL LABORATORY PROFICIENCY TESTING MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 CELL CULTURE
6.3 SPECTROMETRY
6.4 POLYMERASE CHAIN REACTION
6.5 CHROMATOGRAPHY
6.6 IMMUNOASSAYS
6.7 OTHERS
7 GLOBAL LABORATORY PROFICIENCY TESTING MARKET, BY END-USE
7.1 OVERVIEW
7.2 HOSPITALS
7.3 DIAGNOSTIC LABORATORIES
7.4 ACADEMIC RESEARCH
7.5 CONTRACT RESEARCH ORGANIZATIONS
7.6 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8 GLOBAL LABORATORY PROFICIENCY TESTING MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL LABORATORY PROFICIENCY TESTING MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 LGC LIMITED
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 AMERICAN PROFICIENCY INSTITUTE
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 COLLEGE OF AMERICAN PATHOLOGISTS
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 BIO-RAD LABORATORIES, INC.
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 RANDOX LABORATORIES LTD.
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 QACS - THE CHALLENGE TEST LABORATORY
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 MERCK & CO., INC.
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 WEQAS
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 ERA
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 AOAC INTERNATIONAL
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.11 BIPEA
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS
10.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.12 NSI LAB SOLUTIONS
10.12.1 OVERVIEW
10.12.2 FINANCIAL PERFORMANCE
10.12.3 PRODUCT OUTLOOK
10.12.4 KEY DEVELOPMENTS
10.12.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.13 ABSOLUTE STANDARDS, INC.
10.13.1 OVERVIEW
10.13.2 FINANCIAL PERFORMANCE
10.13.3 PRODUCT OUTLOOK
10.13.4 KEY DEVELOPMENTS
10.13.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.14 RCPA
10.14.1 OVERVIEW
10.14.2 FINANCIAL PERFORMANCE
10.14.3 PRODUCT OUTLOOK
10.14.4 KEY DEVELOPMENTS
10.14.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.15 UK NEQAS
10.15.1 OVERVIEW
10.15.2 FINANCIAL PERFORMANCE
10.15.3 PRODUCT OUTLOOK
10.15.4 KEY DEVELOPMENTS
10.15.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.16 INSTAND
10.16.1 OVERVIEW
10.16.2 FINANCIAL PERFORMANCE
10.16.3 PRODUCT OUTLOOK
10.16.4 KEY DEVELOPMENTS
10.16.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved